ACB Q2 F2019 Rundown Dec. 31, 2018

Firstly, this has taken a little more time as the addition of Rec has added lots of new data to play with.  Usually new data takes me a couple of Q’s to get comfortable with. So bear with me as I try out some new things. Secondly, having scanned Twitter and Reddit I find it interesting the reactions that we are seeing.  These LP’s are oil tankers NOT Zodiacs.  You couple that with the absolute Gong Show that rec roll out has been in the majority of the provinces, sprinkle in the fact that no LP seemingly gets their HC licenses when they think…

Continue Reading
LHS Rundown Q3 F2019 Nov 30 ,2018

Open up the fins and MDA to follow along. Sales Sales increased 43% QoQ or by close to $1 million to $3.2 million, which is very similar to the Q2 increase of $1.1 million.  This is largely result of the increase in dispensaries to 7 and delivery hubs to 6.  They have just started including dispensary count and hub count in their MDA to make it easier to keep track of. [George: If you are reading this… a breakdown of store revenue by locations “open for the entire Q” and those that were opened in the Q would be useful in understanding how many…

Continue Reading
LHS – Structure & Current State 01/19

Been awhile since I last looked at LHS. Share price volatility has been somewhat typical for sector, but this one (unlike other US based shops) hasn’t yet seen the love (and revenue expansion) that other operators are starting to show. Let’s see what the financials have to say…. $1MM/month in revenues reported. Promise of more stores opening underway - IIRC, was to be 25 14 of them by end of February. They’re stating they’ll have 14 up and operating by June. Some good news, in that an operator in the state is allowed up to 25 stores - it's been bumped up to 30 now.…

Continue Reading
Organigram Rundown Q1 F2019 Nov 30, 2018

Hot damn!!  An LP with POSITIVE Net Operating Profit!!  OGI will now run the risk of being added to TheCannalysts “biased” list of LP’s that we spread and analyze. /s Open up the fins and MDA and follow along. Plenty of new info and data in the MDA to wrap your head around.  Some pretty decent disclosure by OGI.  Hoping other LP’s give as much [or more] disclosure. Gross Profit margins per unit per segment were particularly interesting I did like the following comment from their MDA, that I thought I’d point out… Those are most of the elements I look at too. Sales:…

Continue Reading
Organigram Q4 F2018 Rundown – Aug 31, 2018

OK… you may have read my Bah Humbug comment on the Sports Bar last night about Q4’s and how I wished that company’s would lay out the Q4 versus just doing an Annual aggregation.  Here is why…   Organigram 9 mos YTD 12 mos F2018 Delta Reported via MDA 31-May-18 31-Aug-18 Q4 F2018 Q4 F2018 Sales $9,611 $11,936 $2,325 $3,205 Sales returns $489 $493 $4 $8 Net Sales $10,100 $12,429 $2,329 $3,213 Cost of Sales $4,009 $4,659 $650 $1,068 Indirect production costs $1,002 $1,289 $287 $287   $5,011 $5,948 $937 $1,355 Gross Margin B4 IFRS $5,089 $6,481 $1,392 $1,858 Fair Value adjustments $15,172 $46,018…

Continue Reading
Close Menu